Bevacizumab Biosimilar - Research Grade
Catalogue Number: ICH4003-ICB
| Manufacturer: | IchorBio |
| Type: | Recombinant Monoclonal |
| Alias: | vascular endothelial growth factor |
| Shipping Condition: | Blue Ice |
| Unit(s): | 10 mg, 20 mg, 5 mg, 50 mg, 1 mg, 100 mg, 200 mg |
| Host name: | |
| Clone: | |
| Isotype: | IgG1 |
| Immunogen: |
Description
Description: Bevacizumab biosimilar is vascular endothelial growth factor directed antibody. Bevacizumab biosimilar is a recombinant humanized monoclonal IgG1 antibody that contains human framework regions and murine complementarity-determining regions. Bevacizumab biosimilar has an approximate molecular weight of 149 kDa. Bevacizumab is produced in a mammalian cell (Chinese Hamster Ovary) expression system in a nutrient medium.
Additional Text
Gene Name
VEGFA
Gene ID
7422
Uniprot ID
P15692
Purification
Protein A/G Purified
Concentration
1-5 mg/ml
Antibody Clonality
Recombinant Monoclonal
Storage Note
Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
ICH4003 Datasheet
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations